Atlas Trials

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Clinical trial NCT01280643 · TERMINATED

Trial details

NCT number
NCT01280643
Sponsor
Fox Chase Cancer Center
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2010-03-01
Primary completion
2013-07-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.